Janux

Chemicals & Related Products · California, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

10955 Vista Sorrento Pkwy Ste 200, San D...

Phone Number

(858) 751-4493

Revenue

$23.3 Million

Stock Symbol

JANX

Industry

Chemicals & Related Products Manufacturing Business Services Research & Development

About Janux

Janux Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing innovative immunotherapies for the treatment of cancer. The company specializes in creating next-generation biologic medicines that harness the power of the immune system to recognize and eliminate cancer cells while reducing unwanted effects on healthy tissues. Its research activities are centered on developing proprietary therapeutic platforms that improve the safety, precision, and effectiveness of cancer immunotherapy through advanced protein engineering and targeted immune activation.Explore more
Janux's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: JANXShow more

Janux Org Chart

PhoneEmail
TD
United States flag for contact location.

Chief Scientific Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
NA
United States flag for contact location.

Director, Analytical Development

PhoneEmail
MB
United States flag for contact location.

Senior Director, Gxp Quality Assurance

PhoneEmail
EM
United States flag for contact location.

Associate Director, Quality Assurance

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Janux

Compare insights from companies similar to Janux, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Janux

$23.3M
51-200
Public
$458.5M
2017
TD
Thomas DiRaimondoChief Scientific Officer
$89.5M
51-200
Public
$177.8M
2016
Jingsong Wang, Founder, Chairman & Chief Executive Officer & Executive Director at Harbour BioMed
Jingsong WangFounder, Chairman & CEO & Executive Director
$14.1M
51-200
Private
-
2003
JB
Jeffrey BrillAssociate Director, Clinical Development
$11.1M
51-200
Private
-
2014
$7.2M
11-50
Private
<$5M
2014
HZ
Hongjian ZhuGlobal Senior VP, Head of Statistics & Data Science, Systimmune Inc
<$5M
51-200
Private
-
2017
<$5M
51-200
Public
$130M
2016
CB
Carsten BrunnPresident & CEO
Illustration of an envelope

Janux Tech Stack

A closer look at the technologies used by Janux

Top Chemicals & Related Products Companies

Frequently Asked Questions Regarding Janux

What is Janux's stock symbol?
Janux's stock symbol is JANX
What is Janux's official website?
Janux's official website is www.januxrx.com
What is Janux's Revenue?
Janux's revenue is $23.3 Million
What is Janux's SIC code?
Janux's SIC: 28,283
What is Janux's NAICS code?
Janux's NAICS: 32,325
How many employees does Janux have?
Janux has 51-200 employees
What industry does Janux belong to?
Janux is in the industry of: Chemicals & Related Products, Manufacturing, Business Services
What is Janux competition?
Janux top competitors include: Neuvogen, Ascenta Therapeutics, SystImmune, Harbour BioMed
What technology does Janux use?
Some of the popular technologies that Janux uses are: DocuSign, WooCommerce, WordPress.org, PHP
How do I contact Janux?
Janux contact info: Phone number: (858) 751-4493 Website: www.januxrx.com
What does Janux do?

Janux Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing innovative immunotherapies for the treatment of cancer. The company specializes in creating next-generation biologic medicines that harness the power of the immune system to recognize and eliminate cancer cells while reducing u... nwanted effects on healthy tissues. Its research activities are centered on developing proprietary therapeutic platforms that improve the safety, precision, and effectiveness of cancer immunotherapy through advanced protein engineering and targeted immune activation.Read More

What are Janux social media links?
Janux Linkedin page Janux Twitter page
Who invested in Janux?
Janux has 9 investors including RA Capital Management, Avalon Ventures, Correlation Ventures and Bregua.
Is Janux a public company?
Yes, Janux is a public company and is traded under the symbol JANX
See more information about Janux

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.